Record overview
Status and phase
Status: NOT_YET_RECRUITING
Phase: PHASE2, PHASE3
Sponsor: Fudan University
Condition: HER2-positive Breast Cancer, Metastatic Breast Cancer
NCT07366840
RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: large_enrollment_target_signal | few_sites_large_trial_signal | rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.